Kunal Potnis, MD (@KunalPotnis) header
Kunal Potnis, MD (@KunalPotnis) profile picture

Heme/onc fellow physician @FredHutch/@UW | @YaleIMed '26, @YaleMed '23, @DukeU '17 | Interested in intersection of hematology/oncology, economics, & policy

Joined July 2012
Photo by Kunal Potnis, MD (@KunalPotnis)Photo by Kunal Potnis, MD (@KunalPotnis)Photo by Kunal Potnis, MD (@KunalPotnis)Photo by Kunal Potnis, MD (@KunalPotnis)Photo by Kunal Potnis, MD (@KunalPotnis)
Kunal Potnis, MD retweeted
Taking a break at the rotunda with @KunalPotnis
2
4
2,511
Kunal Potnis, MD retweeted
First meeting of the day at Rayburn with @KunalPotnis as we #Fight4Hematology
2
12
2,513
Kunal Potnis, MD retweeted
Very proud of the 2026 ALI participants as they #Fight4Hematology
3
2
14
2,681
Kunal Potnis, MD retweeted
July 1 looks a little different this year☺️ Very excited to be with this amazing cohort of @fredhutch fellows & looking forward to many more social hours!
1
3
33
1,807
So wonderful to meet in person today at ASCO -- can't wait for the adventure ahead in Seattle!
Got to meet my future co-fellow Dr Kunal Potnis at #ASCO26!! Loved that we got to also spend some time with our @fredhutch PD Dr Menon this afternoon🫶 Very excited for this next chapter for us and to be in Seattle very soon!
1
2
286
Thank you @OncLearnNetwork for the opportunity to discuss our team's recent #breastcancer cost-effectiveness work at #ASCO25
Kunal Potnis, MD, discusses an analysis of the cost-effectiveness of #ribociclib plus endocrine therapy compared to endocrine therapy alone among patients with HR-positive, HER2-negative early breast cancer. Learn more: hubs.ly/Q03sjl9x0 #medtwitter #onctwitter
4
574
Kunal Potnis, MD retweeted
We are now diving into the tumor-gut axis in the aRCC field as well; Lower levels of MAdCAM-1 in plasma are associated with more aggressive RCC & are one of the most promising prognostic biomarkers by @ReneeSaliby @ASCO @BraunMDPhD @DrChoueiri @YaleCancer @YaleMed
3
26
1,189
Kunal Potnis, MD retweeted
.@KunalPotnis shares that at current pricing, ribociclib w endocrine therapy is not expected to be cost-effective compared to endocrine therapy alone for pts with HR+ HER2- early #breastcancer in the US. #ASCO25 @GeorgeGoshuaMD @SmilowCancer @YaleMed @OncoAlert @YaleBreast meetings.asco.org/abstracts-…
5
7
19
2,892
Kunal Potnis, MD retweeted
.@KunalPotnis reveals that at the current pricing, eltrombopag plus traditional immunosuppressive therapy is unlikely to be a cost-effective treatment for adults with severe aplastic anemia in the US. #ASH24 @GeorgeGoshuaMD @YaleHematology @SmilowCancer ash.confex.com/ash/2024/webp…
3
9
52
3,344
Kunal Potnis, MD retweeted
Our recent review on targeted therapies in #MDS discussing current landscape and future directions tandfonline.com/doi/full/10.…. Special thanks to Dr. @Dr_AmerZeidan and all co-authors for their guidance and support @TradIMYale @YaleCancer @YaleHematology
4
7
51
4,545
Congratulations and welcome to the newest members of the @TradIMYale family!!! Can't wait to meet and work with you all in the near future. @YaleIMed #MatchDay2024
Congratulations to the newly matched residents in our Internal Medicine Traditional Residency Program! Welcome to @YaleMed @Yale @YNHH! 🧵 #MatchDay2024 #Residency #MedTwitter #Match2024 @MarkDSiegel1 @TradIMYale
1
32
3,754
Kunal Potnis, MD retweeted
In recognition of his innovation, @GeorgeGoshuaMD has been named a Young Explorer Award finalist by NOMIS & @ScienceMagazine. Dr. Goshua shared how mathematical models can hold the key to equitable patient care in, "Napkin math can change the world." bit.ly/3sxA1HE
5
9
3
46
16,633
Awesome time presenting work examining the #costeffectiveness of novel therapies (BiTE versus CAR-T) for relapsed/refractory multiple myeloma at #SMDM23 in Philadelphia this weekend
3
3
1
47
7,915
Big thanks to team that includes @sfhYALE, @GeorgeGoshuaMD, & @YuxinLiu_03 (along with #DrBar and #Karthik). Also grateful to @TradIMYale and @YaleIMed for their support!
5
804
🎆Is prophylactic emicizumab cost-effective in patients with moderate or mild hemophilia A in the U.S.? We explored this question in our recent analysis in @AJHematology. A short 🧵 (1/10) onlinelibrary.wiley.com/doi/…
2
8
1
36
15,251
Immensely grateful for the outstanding mentorship from @GeorgeGoshuaMD on this project. Also very thankful for the important and generous insights from @hmkyale, @AnkurFactorial, and @SatokoItoMDPhD (along with #DrKempton, #DrBona, and #Giri), who all taught me so much (10/10)
2
4
849